PerformanceRiskValuationProfitabilityCashflowLiquidityESGRevenue & Geographic ExposureForecastFinancial GrowthIncome GrowthCashflow GrowthBalance Sheet Growth
Tilray Brands, Inc. (TLRY.TO)
2.000.05 (2.56%)
1.90 - 2.15
0.48 - 2.54
9.88M / 3.06M (Avg.)
-0.59 | -3.40
Helps investors judge whether earnings growth is driven by sustainable operations or temporary factors. Consistent, organic income expansion can justify a higher intrinsic value for patient, long-term investors.
-2.80%
Revenue decline while CRON.TO shows 23.42% growth. Joel Greenblatt would examine competitive position erosion.
9.66%
Cost growth less than half of CRON.TO's 42.80%. David Dodd would verify if cost advantage is structural.
-41.28%
Both companies show declining gross profit. Martin Whitman would check industry conditions.
-39.59%
Both companies show margin pressure. Martin Whitman would check industry conditions.
89.29%
R&D growth above 1.5x CRON.TO's 29.11%. Michael Burry would check for spending discipline.
-7.89%
G&A reduction while CRON.TO shows 0.13% growth. Joel Greenblatt would examine efficiency advantage.
26.17%
Similar marketing expense growth to CRON.TO's 27.67%. Walter Schloss would investigate industry requirements.
-1405.27%
Other expenses reduction while CRON.TO shows 890.02% growth. Joel Greenblatt would examine efficiency.
-25.42%
Operating expenses reduction while CRON.TO shows 70.49% growth. Joel Greenblatt would examine advantage.
-2.94%
Total costs reduction while CRON.TO shows 56.77% growth. Joel Greenblatt would examine advantage.
-1.25%
Interest expense reduction while CRON.TO shows 0.00% growth. Joel Greenblatt would examine advantage.
4.09%
D&A growth less than half of CRON.TO's 135.76%. David Dodd would verify if efficiency is sustainable.
-774.69%
Both companies show EBITDA decline. Martin Whitman would check industry conditions.
86.17%
EBITDA margin growth exceeding 1.5x CRON.TO's 5.71%. David Dodd would verify competitive advantages.
20.03%
Operating income growth while CRON.TO declines. John Neff would investigate advantages.
17.73%
Operating margin growth while CRON.TO declines. John Neff would investigate advantages.
145.72%
Other expenses growth less than half of CRON.TO's 726.94%. David Dodd would verify if advantage is sustainable.
-117.61%
Pre-tax income decline while CRON.TO shows 142.22% growth. Joel Greenblatt would examine position.
-123.88%
Pre-tax margin decline while CRON.TO shows 134.21% growth. Joel Greenblatt would examine position.
15.06%
Tax expense growth while CRON.TO reduces burden. John Neff would investigate differences.
-89.15%
Net income decline while CRON.TO shows 195.34% growth. Joel Greenblatt would examine position.
-94.61%
Net margin decline while CRON.TO shows 177.25% growth. Joel Greenblatt would examine position.
-78.84%
EPS decline while CRON.TO shows 195.20% growth. Joel Greenblatt would examine position.
-78.84%
Diluted EPS decline while CRON.TO shows 195.20% growth. Joel Greenblatt would examine position.
3.24%
Share count change of 3.24% while CRON.TO is stable. Bruce Berkowitz would verify approach.
3.24%
Diluted share change of 3.24% while CRON.TO is stable. Bruce Berkowitz would verify approach.